相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti-malaria Activity in Humanized Mice
Wenhu Zhan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Microbial proteasomes as drug targets
Hao Zhang et al.
PLOS PATHOGENS (2021)
Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis
Michael Thomas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Macrocyclic Peptides that Selectively Inhibit the Mycobacterium tuberculosis Proteasome
Hao Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome
Stanley C. Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Integrating the Impact of Lipophilicity on Potency and Pharmacokinetic Parameters Enables the Use of Diverse Chemical Space during Small Molecule Drug Optimization
Randy R. Miller et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Molecular Mechanisms of Drug Resistance in Plasmodium falciparum Malaria
Kathryn J. Wicht et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 74, 2020 (2020)
Plasmodium berghei K13 Mutations Mediate In Vivo Artemisinin Resistance That Is Reversed by Proteasome Inhibition
Nelson Simwela et al.
MBIO (2020)
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
Susan Wyllie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Improvement of Asparagine Ethylenediamines as Anti-malarial Plasmodium-Selective Proteasome Inhibitors
Wenhu Zhan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents
Barbara H. Stokes et al.
PLOS PATHOGENS (2019)
Selective Phenylimidazole-Based Inhibitors of the Mycobacterium tuberculosis Proteasome
Wenhu Zhan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Drug resistance in Plasmodium
Kasturi Haldar et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance
Laura A. Kirkman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis
Min Zhang et al.
SCIENCE (2018)
Defining the Determinants of Specificity of Plasmodium Proteasome Inhibitors
Euna Yoo et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome
Stanley C. Xie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Structural Basis for the Species-Selective Binding of N,C-Capped Dipeptides to the Mycobacterium tuberculosis Proteasome
Hao-Chi Hsu et al.
BIOCHEMISTRY (2017)
Development of a Potent Inhibitor of the Plasmodium Proteasome with Reduced Mammalian Toxicity
Gregory M. LaMonte et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Inhibition of the Proteasome β2 Site Sensitizes Triple-Negative Breast Cancer Cells to β5 Inhibitors and Suppresses Nrf1 Activation
Emily S. Weyburne et al.
CELL CHEMICAL BIOLOGY (2017)
The cryo-EM structure of the Plasmodium falciparum 20S proteasome and its use in the fight against malaria
Hao Li et al.
FEBS JOURNAL (2016)
Structure- and function-based design of Plasmodium-selective proteasome inhibitors
Hao Li et al.
NATURE (2016)
The novel β2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells
Marianne Kraus et al.
HAEMATOLOGICA (2015)
A novel multiple-stage antimalarial agent that inhibits protein synthesis
Beatriz Baragana et al.
NATURE (2015)
Targeting the Cell Stress Response of Plasmodium falciparum to Overcome Artemisinin Resistance
Con Dogovski et al.
PLOS BIOLOGY (2015)
The novel β2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells
Marianne Kraus et al.
HAEMATOLOGICA (2015)
Assessing Subunit Dependency of the Plasmodium Proteasome Using Small Molecule Inhibitors and Active Site Probes
Hao Li et al.
ACS CHEMICAL BIOLOGY (2014)
Identification of Potent and Selective Non-covalent Inhibitors of the Plasmodium falciparum Proteasome
Hao Li et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
N,C-Capped Dipeptides with Selectivity for Mycobacterial Proteasome over Human Proteasomes: Role of S3 and S1 Binding Pockets
Gang Lin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Validation of the Proteasome as a Therapeutic Target in Plasmodium Using an Epoxyketone Inhibitor with Parasite-Specific Toxicity
Hao Li et al.
CHEMISTRY & BIOLOGY (2012)
Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds
Stephen A. Hitchcock
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets
Lynn Bedford et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit
Christopher Blackburn et al.
BIOCHEMICAL JOURNAL (2010)
History of the discovery of the malaria parasites and their vectors
Francis E. G. Cox
PARASITES & VECTORS (2010)
Inhibitors selective for mycobacterial versus human proteasomes
Gang Lin et al.
NATURE (2009)
A hierarchical approach to all-atom protein loop prediction
MP Jacobson et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
The proteasome: A suitable antineoplastic target
J Adams
NATURE REVIEWS CANCER (2004)
On the role of the crystal environment in determining protein side-chain conformations
MP Jacobson et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
分享论文
